Form 4: Ligand Pharmaceuticals Executive Sells Shares
Insider Transaction (Form 4)
Andrew Reardon, CLO & Secretary of Ligand Pharmaceuticals Inc, sold 5,000 shares of common stock on September 3, 2026.
Summary
- Open-market sale: disposed of 300 Common Stock at $283.99 ($85,196) on September 3, 2026; holds 41,214 after (Direct).
- Open-market sale: disposed of 1,800 Common Stock at $285.17 ($513,301) on September 3, 2026; holds 39,414 after (Direct).
- Open-market sale: disposed of 2,115 Common Stock at $286.36 ($605,649) on September 3, 2026; holds 37,299 after (Direct).
- Open-market sale: disposed of 385 Common Stock at $287.53 ($110,697) on September 3, 2026; holds 36,914 after (Direct).
- Open-market sale: disposed of 400 Common Stock at $288.98 ($115,592) on September 3, 2026; holds 36,514 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,430,434 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Andrew Reardon — Officer (CLO & Secretary)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-03 | Open-market sale | Common Stock | 300 | $284 | $85.2K | 41,214 |
| 2026-09-03 | Open-market sale | Common Stock | 1,800 | $285 | $513.3K | 39,414 |
| 2026-09-03 | Open-market sale | Common Stock | 2,115 | $286 | $605.6K | 37,299 |
| 2026-09-03 | Open-market sale | Common Stock | 385 | $288 | $110.7K | 36,914 |
| 2026-09-03 | Open-market sale | Common Stock | 400 | $289 | $115.6K | 36,514 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-03 | Open-market sale (300 shares) |
| 2026-09-03 | Open-market sale (1,800 shares) |
| 2026-09-03 | Open-market sale (2,115 shares) |
| 2026-09-03 | Open-market sale (385 shares) |
| 2026-09-03 | Open-market sale (400 shares) |
Keywords
insider transaction, Form 4, LGND, LIGAND PHARMACEUTICALS INC, bearish, Andrew Reardon
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.